...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Apabetalone’s Positive Impact on COVID-19 in Human Lung Cells Published in Biomedicines
4
Apr 20, 2021 09:45AM
2
Apr 20, 2021 10:41AM

Well how about this:

"This selective inhibition of apabetalone on BD2 produces a specific set of biological effects with potentially important benefits for patients with high-risk cardiovascular disease, diabetes mellitus, chronic kidney disease, end-stage renal disease treated with hemodialysis, neurodegenerative disease, Fabry disease, peripheral artery disease and other orphan diseases, while maintaining a well described safety profile."

 

 

Share
New Message
Please login to post a reply